The UltraScan™ 650 is the first and only FDA-approved bone sonometer that measures bone mineral density (BMD), the most important factor in determining the risk of osteoporotic fracture. Conventional bone sonometers measure parameters like SOS and/or BUA. These parameters have poor correlation with BMD, usually less than 0.8, and thus these devices perform poorly in terms of identifying those individuals with osteoporosis. By contrast, the UltraScan™ 650 uses novel patented net time delay (NTD) technology which allows measurement of the quantity of bone, which in turn provides a direct evaluation of BMD; thus the UltraScan™ 650 is a true "ultrasound bone densitometer". Clinical studies on the UltraScan™ 650 show that its output, BMDUS, is highly correlated (r = 0.931) with x-ray based (DXA) measures of BMD. BMDDXA has‒‒until now that is‒‒been the “gold standard” for bone assessment. Now, with the availability of the UltraScan™ 650, BMD can be measured without the need for DXA, without the ionizing radiation of x-rays, at lower cost and in less time (only 10 seconds).
ACCURATE & RELIABLE
Osteoporotic fracture risk assessment as discriminating as DXA. Provides a measurement of BMD as would be measured by DXA, with a correlation of 0.93 and a precision of 2%. A report identical to one produced by an x-ray (DXA) machine with BMD in grams/cm2, T- and z- scores makes the UltraScan™ 650 an ideal tool for clinically diagnosing and managing osteoporosis.
FAST & EASY
A quick and comfortable exam. BMD assessment takes just seconds‒‒10 to be exact. And all your patients must do is roll up their sleeve (foot not needed).